XML 21 R25.htm IDEA: XBRL DOCUMENT v2.4.1.9
Debt (Tables)
3 Months Ended
Mar. 31, 2015
Debt Instrument [Line Items]  
Schedule of principal amounts, unamortized discount and net carrying amounts
The following table sets forth information related to the 2033 Senior Notes which is included our Condensed Consolidated Balance Sheets as of March 31, 2015:
(In thousands)
Embedded conversion option
 
2033 Senior Notes
 
Discount
 
Total
Balance at December 31, 2014
$
65,947

 
$
87,642

 
$
(22,135
)
 
$
131,454

Amortization of debt discount

 

 
1,056

 
1,056

Change in fair value of embedded derivative
53,730

 

 

 
53,730

Conversion
(51,890
)
 
(36,442
)
 
8,765

 
(79,567
)
Balance at March 31, 2015
$
67,787

 
$
51,200

 
$
(12,314
)
 
$
106,673

Summary of lines of credit
The following table summarizes the amounts outstanding under the Chilean and Spanish lines of credit:
(Dollars in thousands)
 
 
 
 
 
 Balance Outstanding
Lender
 
Interest rate on
borrowings at March 31, 2015
 
Credit line
capacity
 
March 31,
2015
 
December 31,
2014
Itau Bank
 
6.00%
 
$1,800
 
$918
 
$965
Bank of Chile
 
6.34%
 
2,250
 
805
 
1,410
BICE Bank
 
6.16%
 
1,700
 
1,340
 
1,249
BBVA Bank
 
5.00%
 
2,300
 
1,723
 
795
Penta Bank
 
7.34%
 
1,200
 
962
 
1,008
Security Bank
 
6.16%
 
940
 
334
 
361
Estado Bank
 
5.30%
 
2,800
 
1,811
 
1,870
BBVA Bank
 
4.75%
 
271
 
 
Total
 
 
 
$13,261
 
$7,893
 
$7,658
OPKO Health Europe  
Debt Instrument [Line Items]  
Schedule of principal amounts, unamortized discount and net carrying amounts
At March 31, 2015 and December 31, 2014, we had mortgage notes and other debt related to OPKO Health Europe as follows:
(In thousands)
March 31,
2015
 
December 31,
2014
Current portion of notes payable
$
361

 
$
608

Other long-term liabilities
2,185

 
2,435

Total mortgage notes and other debt
$
2,546

 
$
3,043

Notes  
Debt Instrument [Line Items]  
Inputs to lattice model used to value the embedded derivative
The following table sets forth the inputs to the lattice model used to value the embedded derivative:
 
March 31, 2015
Stock price
$14.17
Conversion Rate
141.4827
Conversion Price
$7.07
Maturity date
February 1, 2033
Risk-free interest rate
1.09%
Estimated stock volatility
43%
Estimated credit spread
1043 basis points
Fair value of notes with and without the embedded derivatives and fair value of embedded derivatives
The following table sets forth the fair value of the 2033 Senior Notes with and without the embedded derivatives, and the fair value of the embedded derivatives at March 31, 2015. At March 31, 2015 the principal amount of the 2033 Senior Notes was $51.2 million:
(In thousands)
March 31, 2015
Fair value of 2033 Senior Notes:
 
With the embedded derivatives
$
106,170

Without the embedded derivatives
$
38,383

Estimated fair value of the embedded derivatives
$
67,787